Advertisement

Topics

Latest "Serenity Pharmaceuticals" News Stories

09:42 EST 19th February 2019 | BioPortfolio

Here are the most relevant search results for "Serenity Pharmaceuticals" found in our extensive news archives from over 250 global news sources.

More Information about Serenity Pharmaceuticals on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Serenity Pharmaceuticals for you to read. Along with our medical data and news we also list Serenity Pharmaceuticals Clinical Trials, which are updated daily. BioPortfolio also has a large database of Serenity Pharmaceuticals Companies for you to search.

Showing "Serenity Pharmaceuticals" News Articles 1–25 of 10,000+

Relevant

Wilderness Rx for Pain

(MedPage Today) -- Adaptation and serenity have worked for millennia


Serenity Addiction Centres and Steps Counselling Teams Up to Prevent Drink and Drug Driving

In time for the holidays, the alcohol and drug detox providers together invested £100,000 into a drink and driving program. UNITED KINGDOM (PRWEB) December 24, 2018 The festive season finds many behind the wheel while under the influence across the United Kingdom. Knowing the seriousness of driving while drinking or using drugs, Serenity Addiction Centres and Steps Counselling has joined tog...

Sunspire Health Texas Announces Name Change to Serenity View Recovery Center

Sunspire Health Texas, a community-based addiction treatment center which is part of the Meadows Behavioral Healthcare network of nationwide specialized behavioral healthcare programs, is excited to announce that, effective immediately, it will be known as Serenity View Recovery Center. As Serenity View Recovery Center, the facility will continue to offer ...


PreveCeutical Medical strikes licensing deal with Asterion Cannabis for three natural health products

The products in question are three natural sleep aids, named "Blissful Sleep", "Blissful Sleep Ex" and "Skullcap Serenity".

The Ritz-Carlton, Amelia Island Unveils 2019 Wellness Programming hosting Healthy is the New Happy Weekend Retreat with Bestselling Author and Yoga Expert Dave Romanelli

AMELIA ISLAND, Fla. (PRWEB) December 14, 2018 In an effort to further enhance its holistic wellness experience resort-wide, The Ritz-Carlton, Amelia Island will expand its platforms emphasizing mindfulness, serenity and healthy living by introducing quarterly wellness retreats with acclaimed...

Probably Relevant

AMAG Pharmaceuticals to Acquire Perosphere Pharmaceuticals

AMAG Pharmaceuticals said today it has agreed to acquire Perosphere Pharmaceuticals for up to $415 million, in a deal that the buyer said will expand its pipeline, and especially its presence in hematology with Perosphere’s next-generation anticoagulant reversal candidate ciraparantag (PER977). Ciraparantag is an intravenously-administered synthetic small molecule anticoagulant reversal agen...

Deals and M&As this week: Aridis Pharmaceuticals, Xeris Pharmaceuticals, Astellas Pharma

Aridis Pharmaceuticals has raised $26m through an initial public offering of two million shares of its common stock priced at $13...Read More... The post Deals and M&As this week: Aridis Pharmaceuticals, Xeris Pharmaceuticals, Astellas Pharma appeared first on Drug Development Technology.

InMed Pharmaceuticals - Entering the clinic by the end of the year

Edison Investment Research - Pharmaceuticals & healthcare - InMed Pharmaceuticals: InMed recently reported results for the second quarter of FY19 and is on track to bring INM-750 for epidermolysis ...

GW Pharmaceuticals plc: GW Pharmaceuticals presents latest cannabidiol oral solution (CBD) data at the 13th European Congress of Epileptology

VIENNA, Austria, Aug. 28, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the development and commercialization of cannabinoid prescr...

ACADIA Pharmaceuticals and Neuren Pharmaceuticals Announce Exclusive License Agreement

ACADIA Pharmaceuticals (NASDAQ:ACAD) and Neuren Pharmaceuticals (ASX:NEU) announced today that they have entered into an exclusive North American License Agreement for the development and commercialization of trofinetide for Rett syndrome and other indications. Neuren retains rights to develop and commercialize trofinetide for all indications outside of North America. As quoted in the press releas...

Checkmate Pharmaceuticals Appoints Barry Labinger President & CEO

Barry Labinger has joined Checkmate Pharmaceuticals as president and CEO, the Cambridge, MA, company announced Wednesday. Labinger comes to the cancer drug developer from Biothera Pharmaceuticals, where he was president and CEO. His experience also includes leadership positions at Human Genome Sciences, 3M Pharmaceuticals, and Immunex. Labinger is succeeding Arthur Krieg, who is shifting to [̷...

Telix Pharmaceuticals Limited: Telix Pharmaceuticals Acquires Advanced Nuclear Medicine Ingredients (ANMI) SA

MELBOURNE, Australia, BRUSSELS and LIÈGE, Belgium, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) ("Telix", the "Company"), a clinical-stage biopharmaceutical company foc...

Nuvo Pharmaceuticals to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals

NewsUpon closing of the Proposed Transaction, Nuvo would pay Aralez $110 million in cash,

M&As this week: Astellas Pharma, Taisho Pharmaceuticals, AMAG Pharmaceuticals

Astellas Pharma has completed the acquisition of Potenza Therapeutics for $405m. Astellas made an upfront payment of $164.6m and has...Read More... The post M&As this week: Astellas Pharma, Taisho Pharmaceuticals, AMAG Pharmaceuticals appeared first on Pharmaceutical Tech

Deals this week: Amicus Therapeutics, Janssen Pharmaceuticals, Ionis Pharmaceuticals

Amicus Therapeutics has entered a collaboration with the Perelman School of Medicine at the University of Pennsylvania to develop new...Read More... The post Deals this week: Amicus Therapeutics, Janssen Pharmaceuticals, Ionis Pharmaceuticals appeared first on Pharmaceutical Technology.

AMAG Pharma to buy US─based biopharma company, Perosphere Pharmaceuticals

AMAG Pharmaceuticals, Inc. has entered into a definitive agreement to acquire Perosphere Pharmaceuticals Inc, a private biopharmaceutical company.

Bausch Health makes $200m bid for bankrupt Synergy Pharmaceuticals

Canada-based Bausch Health Companies (previously Valeant Pharmaceuticals) has entered into a definitive agreement to acquire select assets of Synergy Pharmaceuticals...Read More... The post Bausch Health makes $200m bid for bankrupt Synergy Pharmaceuticals appeared first on Pharmaceutical Technology.

Cantex Pharmaceuticals, Inc. Receives FDA Fast Track Designation For CX-01 For The Treatment Of Patients Over Age 60 With Newly Diagnosed Acute Myeloid Leukemia (AML)

WESTON, Fla., Aug. 27, 2018 /PRNewswire/ -- Cantex Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing proprietary pharmaceuticals for the treatment of cancer, today announced that the U.S. Food and Drug Administration...

Sunesis Pharmaceuticals - Vecabrutinib study advances

Edison Investment Research - Pharmaceuticals & healthcare - Sunesis Pharmaceuticals: In January 2019 Sunesis announced that its Phase Ib/II study of vecabrutinib for B-cell cancers advanced to the ...

Nuvo Pharmaceuticals Intends To Acquire Commercial Products And Infrastructure From Aralez Pharmaceuticals

NewsUnder the terms of the Proposed Transaction, Nuvo would acquire Aralez's Canadian specialty pharmaceutical business.

Aralez completes sale of drug rights to Nuvo Pharmaceuticals for $110m

Canada-based Aralez Pharmaceuticals has completed the divestment of more than 20 medicines under its portfolio to Nuvo Pharmaceuticals for a...Read More... The post Aralez completes sale of drug rights to Nuvo Pharmaceuticals for $110m appeared first on Pharmaceutical Technology.

Emerald Health Pharmaceuticals Inc.: Emerald Health Pharmaceuticals Announces Scientific Innovation Award Received at International Cannabis Research Society Conference

SAN DIEGO, CA / ACCESSWIRE / August 21, 2018 / Emerald Health Pharmaceuticals Inc. (EHP), a company developing medicines based on cannabinoid science, today announced that Carmen Navarrete, Ph.D., ...

AMAG Pharmaceuticals Enters Into Definitive Merger Agreement to Acquire Perosphere Pharmaceuticals

Next Generation Anticoagulant Reversal Agent, Ciraparantag, Will Add Innovative Clinical Stage Asset to AMAG’s Hematology Portfolio Conference call scheduled for 8:00 a.m. ET today WALTHAM, Mass., Dec. 13, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced it has entered into a definitive agreement to acquire Perosphere Pharmaceuticals Inc., a private biopha...

RespireRx Pharmaceuticals Inc. Executives Presenting at the International Cannabinoid Derived Pharmaceuticals Summit

December 11 – 12, 2018 Workshops, December 10, 2018 The Revere Hotel 200 Stuart St., Boston, MA SVP R&D leading workshop on Financial Planning and Commercial DevelopmentSVP R&D to present A Translational R&D Program with Dronabinol for OSACFO participating on panel on Funding the Commercial Development of Pharmaceutical Cannabinoids Glen Rock, N.J., Dec. 10, 2018 (GLOBE NEW...

Glenmark Pharmaceuticals to establish new company in US

India-based Glenmark Pharmaceuticals is set to spin-off its innovation business into a new company in the US to increase focus...Read More... The post Glenmark Pharmaceuticals to establish new company in US appeared first on Pharmaceutical Technology.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks